Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment.
about
Post-translational modifications of recombinant human lysyl oxidase-like 2 (rhLOXL2) secreted from Drosophila S2 cellsMegakaryocyte pathology and bone marrow fibrosis: the lysyl oxidase connectionNew perspectives on management of idiopathic pulmonary fibrosisPromising Therapy Candidates for Liver FibrosisInfluence of Immune Myeloid Cells on the Extracellular Matrix During Cancer MetastasisPharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic FibrosisHepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next StepA review of the medical treatment of primary sclerosing cholangitis in the 21st centuryThe Role of the Fibroblast in Inflammatory Upper Airway ConditionsTargeting ECM Disrupts Cancer ProgressionAlways cleave up your mess: targeting collagen degradation to treat tissue fibrosisRecent developments in myofibroblast biology: paradigms for connective tissue remodelingRemodelling the extracellular matrix in development and diseaseThe wound healing, chronic fibrosis, and cancer progression triadTumor stroma as targets for cancer therapyCellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosisCancer-associated fibroblasts in digestive tumorsMolecular mechanism and treatment of viral hepatitis-related liver fibrosis.Pulmonary fibrosis: patterns and perpetratorsPathobiology of wound healing after glaucoma filtration surgeryThe extracellular matrix - the under-recognized element in lung disease?Molecular Cues Guiding Matrix Stiffness in Liver FibrosisClinical Advancements in the Targeted Therapies against Liver Fibrosis.Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatmentStrategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014.Hepatic consequences of vascular adhesion protein-1 expressionLysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesisDirect isolation of myofibroblasts and fibroblasts from bleomycin-injured lungs reveals their functional similarities and differencesThe role of lysyl oxidase, the extracellular matrix and the pre-metastatic niche in bone metastasisWhy don't we get more cancer? A proposed role of the microenvironment in restraining cancer progressionMechanisms of fibrosis: therapeutic translation for fibrotic diseasePromising therapies for treatment of nonalcoholic steatohepatitis.Magnetic Resonance Elastography Shear Wave Velocity Correlates with Liver Fibrosis and Hepatic Venous Pressure Gradient in Adults with Advanced Liver Disease.Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injuryCurrent status of novel antifibrotic therapies in patients with chronic liver diseaseRemodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer.Evolving therapies for liver fibrosis.The Extracellular Matrix in Epithelial Ovarian Cancer - A Piece of a Puzzle.Ruxolitinib: long-term management of patients with myelofibrosis and future directions in the treatment of myeloproliferative neoplasmsCellular and molecular mechanisms in kidney fibrosis.
P2860
Q24309073-14F72E2C-470F-40E1-B0EB-9B38A6FF7B2AQ24607513-5880B97B-8F11-4D8C-BEC2-747AB8372DB8Q26765586-343193E3-EB25-4AE9-8D58-829B6A13AD45Q26766727-C9084854-5352-414A-B8C4-ED6A5D33B4C2Q26767150-0BA01270-E5F1-41CD-80BA-5861E5D32FB6Q26768588-5569E8F7-8D5F-4F98-9F53-D08429F889EAQ26771518-6B2D0BA3-A705-4A2A-B35E-4EC6DC27A040Q26771816-5487E9B2-F244-41E4-B811-53DC71A4F66DQ26774661-9ECD9E17-40C9-45FB-9C18-B13A94677F74Q26779300-851674BE-CD00-496D-AF67-10ABE290A448Q26827393-14A23A07-8CFE-457E-854D-3709CCD216B8Q26863751-2C4FEE15-1FD4-4952-A2BE-969520C8221EQ26864798-2594EA2D-93DE-48FE-B0C1-4F1593256A66Q27014616-EE87E52E-C36B-4CE6-A39C-C76D8434CD75Q27015980-4CE17825-7154-4D08-93C1-F41BEEE9B5DCQ27021577-171BE72B-644F-4235-9087-A1620168ABE9Q27022816-6F37AFF4-910B-49DB-AA0D-8DBF8F5EAF06Q27692609-A2DAEDF6-19C9-46DA-A917-A39F9FBCF58CQ27694249-E8EB92BE-17EB-4E2D-B5DC-BABC245F0B5AQ28073856-B4DA3911-3D9D-4035-8A75-0108418EA2E2Q28075842-2875FF22-7C83-43F1-9279-60F729A88492Q28077583-B6A99608-1520-464E-AA12-8E4937003AE3Q28078684-8AC443E1-D00A-4510-8B0F-2A308F402415Q28080136-5BC0FB10-3524-4FCE-8CFE-9DFD2273ACECQ28082065-8A251FAB-0138-4849-B43E-13A1833935FAQ28236182-5AD05CF0-F5CC-4D22-B4AD-F95EE9F548D6Q28280138-1F4EC93E-4ECD-4678-8FCE-6DF6DDE625D0Q28387716-3392C2C1-2A75-4F1D-B84F-8B32ED1798FCQ28597660-594B54CA-0BFA-48B7-827C-1C0293D807B5Q29614274-EAF7DE70-23C8-4BF6-95E8-C01ADDA1850EQ29620307-722A317F-D204-4F62-BE38-105992A368DBQ30248578-E53BC436-FB88-4A25-B54C-82F28DFBFDA1Q30357059-67979D9C-CBFF-406B-874A-A4879346840CQ30414261-9692F8CA-2765-4CEF-94A5-26E55E5BABD9Q30473375-EE807070-06A3-4863-8AAB-EE0BFF15B5B3Q30476541-FB3C0F91-BD22-4FC1-9180-6C32CE026570Q30539166-E59B8304-D8E7-4B90-A3F6-A26DB145566DQ33361929-59E2A046-0188-4363-8A2E-76A6E2603504Q33417217-2BD5D3CB-609A-4424-B065-31DF4A845A36Q33685938-6734AD34-7193-4DBF-B939-2A43543DC35E
P2860
Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Allosteric inhibition of lysyl ...... a pathologic microenvironment.
@en
Allosteric inhibition of lysyl ...... a pathologic microenvironment.
@nl
type
label
Allosteric inhibition of lysyl ...... a pathologic microenvironment.
@en
Allosteric inhibition of lysyl ...... a pathologic microenvironment.
@nl
prefLabel
Allosteric inhibition of lysyl ...... a pathologic microenvironment.
@en
Allosteric inhibition of lysyl ...... a pathologic microenvironment.
@nl
P2093
P356
P1433
P1476
Allosteric inhibition of lysyl ...... a pathologic microenvironment.
@en
P2093
Alison Holzer
Amanda Mikels
Arleene C Velayo
Brett Jorgensen
Carlos A Garcia
Daniel Tsai
Derek Marshall
Donna Biermann
P2888
P304
P356
10.1038/NM.2208
P407
P577
2010-09-05T00:00:00Z